Invesco
BLUE

Invesco’s bluebird bio BLUE Stock Holding History

Invesco’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,998
Closed -$62.3K – 3763
2024
Q3 		$62.3K Buy
5,998
+1,603
+36% +$26.6K ﹤0.01% 3666
2024
Q2 		$86.5K Buy
4,395
+306
+7% +$6.13K ﹤0.01% 3772
2024
Q1 		$105K Sell
4,089
-672
-14% -$17.2K ﹤0.01% 3732
2023
Q4 		$131K Buy
4,761
+316
+7% +$19.3K ﹤0.01% 3648
2023
Q3 		$270K Buy
4,445
+8
+0.2% +$562 ﹤0.01% 3492
2023
Q2 		$292K Buy
4,437
+107
+2% +$7.83K ﹤0.01% 3505
2023
Q1 		$275K Sell
4,330
-36,212
-89% -$4.14M ﹤0.01% 3527
2022
Q4 		$5.61M Sell
40,542
-35,392
-47% -$4.99M ﹤0.01% 2187
2022
Q3 		$9.61M Buy
75,934
+66,548
+709% +$7.53M ﹤0.01% 1812
2022
Q2 		$777K Buy
9,386
+1,418
+18% +$110K ﹤0.01% 3103
2022
Q1 		$773K Buy
7,968
+4,191
+111% +$553K ﹤0.01% 3194
2021
Q4 		$755K Sell
3,777
-2,748
-42% -$648K ﹤0.01% 3211
2021
Q3 		$1.61M Buy
6,525
+304
+5% +$86.9K ﹤0.01% 2912
2021
Q2 		$2.58M Sell
6,221
-294
-5% -$116K ﹤0.01% 2743
2021
Q1 		$2.54M Buy
6,515
+2,242
+52% +$1.1M ﹤0.01% 2678
2020
Q4 		$2.4M Buy
4,273
+1,631
+62% +$1.03M ﹤0.01% 2548
2020
Q3 		$1.85M Sell
2,642
-25
-0.9% -$19.5K ﹤0.01% 2531
2020
Q2 		$2.11M Sell
2,667
-266
-9% -$201K ﹤0.01% 2456
2020
Q1 		$1.75M Sell
2,933
-7,523
-72% -$7.33M ﹤0.01% 2472
2019
Q4 		$11.9M Sell
10,456
-69,787
-87% -$75.9M ﹤0.01% 1664
2019
Q3 		$95.4M Sell
80,243
-1,121
-1% -$1.71M 0.03% 678
2019
Q2 		$134M Buy
81,364
+73,216
+899% +$127M 0.03% 571
2019
Q1 		$16.6M Buy
8,148
+397
+5% +$699K 0.01% 1335
2018
Q4 		$9.96M Buy
7,751
+848
+12% +$1.3M ﹤0.01% 1538
2018
Q3 		$13.1M Sell
6,903
-3,848
-36% -$7.95M ﹤0.01% 1555
2018
Q2 		$21.9M Sell
10,751
-1,400
-12% -$3.19M 0.01% 1185
2018
Q1 		$26.9M Buy
12,151
+1,356
+13% +$3.45M 0.01% 1019
2017
Q4 		$24.9M Sell
10,795
-4,020
-27% -$8.16M 0.01% 1093
2017
Q3 		$26.4M Buy
14,815
+2,181
+17% +$3.05M 0.01% 1063
2017
Q2 		$17.2M Sell
12,634
-5,162
-29% -$6.23M 0.01% 1260
2017
Q1 		$21M Sell
17,796
-1,871
-10% -$1.91M 0.01% 1160
2016
Q4 		$15.7M Buy
19,667
+1,885
+11% +$1.5M 0.01% 1269
2016
Q3 		$15.6M Buy
17,782
+154
+0.9% +$112K 0.01% 1256
2016
Q2 		$9.88M Sell
17,628
-338
-2% -$191K ﹤0.01% 1446
2016
Q1 		$9.89M Buy
17,966
+417
+2% +$256K ﹤0.01% 1438
2015
Q4 		$14.6M Buy
17,549
+244
+1% +$244K 0.01% 1300
2015
Q3 		$19.2M Sell
17,305
-1,881
-10% -$3.43M 0.01% 1160
2015
Q2 		$41.8M Buy
19,186
+594
+3% +$1.21M 0.02% 881
2015
Q1 		$29.1M Buy
18,592
+1,961
+12% +$2.59M 0.01% 1037
2014
Q4 		$19.8M Buy
16,631
+11,522
+226% +$7.7M 0.01% 1176
2014
Q3 		$2.38M Buy
5,109
+2,579
+102% +$1.19M ﹤0.01% 2437
2014
Q2 		$1.26M Buy
+2,530
New +$811K ﹤0.01% 2866

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Invesco's BLUE Position: Q4 2024 in Review

Invesco sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 5,998 shares — an estimated $62.3K sold.

Invesco first reported a position in BLUE in Q2 2014 and held it in 42 quarters. The position peaked at $134M in Q2 2019. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Invesco reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 5,998 bluebird bio shares in Q4 2024, an estimated $62.3K.
  • Invesco first reported a position in bluebird bio in Q2 2014 and held it in 42 quarters.
  • Invesco's bluebird bio position peaked at $134M in Q2 2019.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.